Literature DB >> 22971462

In vitro cell subtype-specific transduction of adeno-associated virus in mouse and marmoset retinal explant culture.

Yukihiro Baba1, Shinya Satoh, Makoto Otsu, Erika Sasaki, Takashi Okada, Sumiko Watanabe.   

Abstract

Adeno-associated virus (AAV) is a non-pathogenic human parvovirus that can infect both non-proliferating and proliferating cells. Owing to its favorable safety profile, AAV is regarded as suitable for clinical purposes such as gene therapy. The target cell types of AAV depend largely on the serotype. In the retina, AAV has been used to introduce exogenous genes into photoreceptors, and photoreceptor-specific enhancers/promoters are used in most cases. Therefore, serotype specificity of AAV in retinal subtypes is unclear, particularly in vitro. We compared its infection profile in mouse and monkey retinas using EGFP under the control of the CAG promoter, which expressed the gene ubiquitously and strongly regardless of cell type. AAV1, 8, and 9 infected the horizontal cells when an embryonic day-17 retina was used as a host. Amacrine cell was also a major target of AAVs, and a small number of rod photoreceptors were infected. When adult retinas were used as a host, the main target of AAV was Müller glia. A small number of rod photoreceptors were also infected. In the adult common marmoset retina, rod and cone photoreceptors were efficiently infected by AAV1, 8, and 9. A portion of the Müller glia and amacrine cells were also infected. In summary, the infection specificity of different AAV serotypes did not differ, but was dependent on the stage of the host retina. In addition, infection specificities differed between mature marmoset retinas and mature mouse retinas.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22971462     DOI: 10.1016/j.biochi.2012.08.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

1.  Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal Explants.

Authors:  Luke A Wiley; Erin R Burnight; Emily E Kaalberg; Chunhua Jiao; Megan J Riker; Jennifer A Halder; Meagan A Luse; Ian C Han; Stephen R Russell; Elliott H Sohn; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Hum Gene Ther       Date:  2018-02-23       Impact factor: 5.695

Review 2.  Advances in gene therapy technologies to treat retinitis pigmentosa.

Authors:  Hilda Petrs-Silva; Rafael Linden
Journal:  Clin Ophthalmol       Date:  2013-12-24

Review 3.  In Vivo Genome Editing as a Therapeutic Approach.

Authors:  Beatrice Xuan Ho; Sharon Jia Hui Loh; Woon Khiong Chan; Boon Seng Soh
Journal:  Int J Mol Sci       Date:  2018-09-12       Impact factor: 5.923

4.  Efficient Ocular Delivery of VCP siRNA via Reverse Magnetofection in RHO P23H Rodent Retina Explants.

Authors:  Merve Sen; Marco Bassetto; Florent Poulhes; Olivier Zelphati; Marius Ueffing; Blanca Arango-Gonzalez
Journal:  Pharmaceutics       Date:  2021-02-06       Impact factor: 6.321

5.  Hydroxylation of N-acetylneuraminic Acid Influences the in vivo Tropism of N-linked Sialic Acid-Binding Adeno-Associated Viruses AAV1, AAV5, and AAV6.

Authors:  Estrella Lopez-Gordo; Alejandro Orlowski; Arthur Wang; Alan Weinberg; Susmita Sahoo; Thomas Weber
Journal:  Front Med (Lausanne)       Date:  2021-12-21

6.  Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy.

Authors:  Takashi Okada; Shin'ichi Takeda
Journal:  Pharmaceuticals (Basel)       Date:  2013-06-27

7.  Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9.

Authors:  Hironori Okada; Hidetoshi Ishibashi; Hiromi Hayashita-Kinoh; Tomoko Chiyo; Yuko Nitahara-Kasahara; Yukihiro Baba; Sumiko Watanabe; Shin'ichi Takeda; Takashi Okada
Journal:  Mol Ther Nucleic Acids       Date:  2013-05-28       Impact factor: 10.183

8.  AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates.

Authors:  Q Lu; T H Ganjawala; E Ivanova; J G Cheng; D Troilo; Z-H Pan
Journal:  Gene Ther       Date:  2016-04-26       Impact factor: 5.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.